Sign up
Log in
12 Health Care Stocks Moving In Monday's After-Market Session
Share
Listen to the news

Gainers

  • China SXT Pharmaceuticals (NASDAQ:SXTC) shares increased by 23.5% to $1.26 during Monday's after-market session. The company's market cap stands at $17.3 million.
  • Beyond Air (NASDAQ:XAIR) stock increased by 21.05% to $0.28. The company's market cap stands at $24.7 million.
  • Annovis Bio (NYSE:ANVS) shares moved upwards by 8.08% to $1.46. The company's market cap stands at $28.4 million.
  • Protagenic Therapeutics (NASDAQ:PTIX) shares rose 7.65% to $0.23. The company's market cap stands at $1.6 million.
  • Adial Pharmaceuticals (NASDAQ:ADIL) shares increased by 7.63% to $0.72. The market value of their outstanding shares is at $4.7 million.
  • cbdMD (AMEX:YCBD) shares rose 7.03% to $0.24. The company's market cap stands at $1.5 million.

Losers

  • Universe Pharmaceuticals (NASDAQ:UPC) shares declined by 15.7% to $3.49 during Monday's after-market session. The company's market cap stands at $53.1 million.
  • ZyVersa Therapeutics (NASDAQ:ZVSA) shares decreased by 11.42% to $0.62. The company's market cap stands at $1.5 million.
  • Medpace Hldgs (NASDAQ:MEDP) stock decreased by 10.04% to $260.0. The market value of their outstanding shares is at $7.9 billion. The company's, Q1 earnings came out today.
  • Precipio (NASDAQ:PRPO) shares fell 9.19% to $5.24. The market value of their outstanding shares is at $7.7 million.
  • Enveric Biosciences (NASDAQ:ENVB) shares declined by 7.57% to $1.1. The company's market cap stands at $2.7 million.
  • Calidi Biotherapeutics (AMEX:CLDI) shares declined by 6.8% to $0.41. The market value of their outstanding shares is at $13.0 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.